![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Drug-Drug Interactions with Direct Acting Antiviral Combination Therapy of ABT-450/r, Ombitasvir and Dasabuvir
|
|
|
Reported by Jules Levin
Presented at the ICAAC 2014 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 5-9, 2014, Washington, DC
R. Menon, P. Badri, U. Das, T. Wang, A. Polepally, A. Khatri, H. Wang, B. Hu, E. Coakley, T. Podsadecki, W. Awni, S. Dutta AbbVie Inc., Research and Development, North Chicago, Illinois 60064, United States
![HCV1.gif](../images/090814/090814-17/HCV1.gif)
![HCV2.gif](../images/090814/090814-17/HCV2.gif)
![HCV3.gif](../images/090814/090814-17/HCV3.gif)
![HCV4.gif](../images/090814/090814-17/HCV4.gif)
![HCV5.gif](../images/090814/090814-17/HCV5.gif)
![HCV6.gif](../images/090814/090814-17/HCV6.gif)
![HCV7.gif](../images/090814/090814-17/HCV7.gif)
![HCV8.gif](../images/090814/090814-17/HCV8.gif)
![HCV9.gif](../images/090814/090814-17/HCV9.gif)
![HCV10.gif](../images/090814/090814-17/HCV10.gif)
![HCV11.gif](../images/090814/090814-17/HCV11.gif)
![HCV12.gif](../images/090814/090814-17/HCV12.gif)
![HCV13.gif](../images/090814/090814-17/HCV13.gif)
![HCV14.gif](../images/090814/090814-17/HCV14.gif)
![HCV15.gif](../images/090814/090814-17/HCV15.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|